Questionnaire-based analysis of mefloquine chemoprophylaxis for malaria in a Japanese population

Journal of Infection and Chemotherapy

Volumn 11, Issue 4, 2005, Pages 196-198

  Matsumura, Takeshi ^a   Fujii, Takeshi ^a   Miura, Toshiyuki ^a   Koibuchi, Tomohiko ^a   Endo, Tokiomi ^a   Nakamura, Hitomi ^a   Odawara, Takashi ^a   Iwamoto, Aikichi ^a   Nakamura, Tetsuya ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adherence; Adverse effect; Chemoprophylaxis; Malaria; Mefloquine; Travel medicine

Indexed keywords

MEFLOQUINE;

ABDOMINAL PAIN; ANOREXIA; ANXIETY; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIZZINESS; DRUG TOLERABILITY; ENDEMIC DISEASE; FEVER; HEADACHE; HEART PALPITATION; HUMAN; INFECTION PREVENTION; INSOMNIA; IRRITABILITY; JAPAN; MALARIA; MALARIA CONTROL; NAUSEA; PATIENT COMPLIANCE; POPULATION RESEARCH; PRESCRIPTION; QUESTIONNAIRE; SIDE EFFECT; SOMNOLENCE; TINNITUS; TRAVEL; UNPLEASANT DREAM;

EID: 24044454981     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-005-0390-2     Document Type: Article

References (12)

1. S Kano M Kimura 2004 Trends in malaria cases in Japan Acta Trop 89 271 8
2. M Kimura A Suzaki Y Matsumoto K Nakajima Y Wataya H Ohtomo 2003 Epidemiological and clinical aspects of malaria inJapan J Travel Med 10 122 7
3. H Ohtomo T Takeuchi 1998 Studies on current trend of imported malaria in Japan Nippon Nettai Igakkai Zasshi 26 151 6
4. AM Croft P Garner 1997 Mefloquine to prevent malaria: a systemic review of trials BMJ 315 1412 6
5. E Wooltorton 2002 Mefloquine: contraindicated in patients with mood, psychotic or seizure disorders Can Med Assoc J 167 1147
6. S Takeshima 1994 Side effects with mefloquine for long-term malaria prophylaxis Nippon Nettai Igakkai Zasshi 22 185 92
7. T Suginuma S Terada K Ieda A Tsuji S Miyamori 1994 Side effects of mefloquine, an antimalarial agent, observed during its chemoprophylactic administration Boei Eisei 41 49 55
8. D Overbosch H Schilthuis U Bienzle RH Behrens KC Kain PD Clarke 2001 Atvaquone-Proguanil versus mefloquine formalaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study Clin Infect Dis 33 1015 21
9. PJ Barrett PD Emmins PD Clarke DJ Bradley 1996 Comparison of adverse effects associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travelers BMJ 313 525 8
10. AM Croft A Herxheimer 2002 Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement? BMC Public Health 2 6 13
11. P Schlagenhauf A Tschopp R Johnson HD Nothdurft B Beck E Schwartz 2003 Tolerability of malaria chemoprophylaxis in non-immune travelers to sub-Saharan Africa: multicentre, randomized, double blind, four arm study BMJ 327 1078 84
12. D Bradley B Bannister 2003 Guidelines for malaria prevention in travelers from the United Kingdom for 2003 Commun Dis Public Health 6 180 99